Literature DB >> 26258664

Memantine Augmentation in a Down's Syndrome Adolescent with Treatment- Resistant Obsessive-Compulsive Disorder.

Scott R Pekrul1, Kate D Fitzgerald1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26258664     DOI: 10.1089/cap.2015.0073

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  1 in total

Review 1.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.